TY - JOUR AU - McDonald, J. AU - Bayrak-Toydemir, P. AU - Pyeritz, R. E. PY - 2011 DA - 2011// TI - Hereditary hemorrhagic telangiectasia: an overview of diagnosis, management, and pathogenesis JO - Genet Med VL - 13 UR - https://doi.org/10.1097/GIM.0b013e3182136d32 DO - 10.1097/GIM.0b013e3182136d32 ID - McDonald2011 ER - TY - JOUR AU - Ardelean, D. S. AU - Letarte, M. PY - 2015 DA - 2015// TI - Anti-angiogenic therapeutic strategies in hereditary hemorrhagic telangiectasia JO - Front Genet VL - 6 UR - https://doi.org/10.3389/fgene.2015.00035 DO - 10.3389/fgene.2015.00035 ID - Ardelean2015 ER - TY - JOUR AU - Sadick, H. AU - Naim, R. AU - Gössler, U. AU - Hörmann, K. AU - Riedel, F. PY - 2005 DA - 2005// TI - Angiogenesis in hereditary hemorrhagic telangiectasia: VEGF165 plasma concentration in correlation to the VEGF expression and microvessel density JO - Int J Mol Med VL - 15 ID - Sadick2005 ER - TY - JOUR AU - Garg, N. AU - Khunger, M. AU - Gupta, A. AU - Kumar, N. PY - 2014 DA - 2014// TI - Optimal management of hereditary hemorrhagic telangiectasia JO - J Blood Med VL - 5 ID - Garg2014 ER - TY - JOUR AU - Dupuis-Girod, S. AU - Ginon, I. AU - Saurin, J. C. AU - Marion, D. AU - Guillot, E. AU - DeCullier, E. PY - 2012 DA - 2012// TI - Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output JO - JAMA VL - 307 UR - https://doi.org/10.1001/jama.2012.250 DO - 10.1001/jama.2012.250 ID - Dupuis-Girod2012 ER - TY - JOUR AU - Riss, D. AU - Burian, M. AU - Wolf, A. AU - Kranebitter, V. AU - Kaider, A. AU - Arnoldner, C. PY - 2015 DA - 2015// TI - Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: a double-blind, randomized, placebo-controlled trial JO - Head Neck VL - 37 UR - https://doi.org/10.1002/hed.23655 DO - 10.1002/hed.23655 ID - Riss2015 ER - TY - JOUR AU - Storch, C. H. AU - Hoeger, P. H. PY - 2010 DA - 2010// TI - Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action JO - Br J Dermatol VL - 163 UR - https://doi.org/10.1111/j.1365-2133.2010.09848.x DO - 10.1111/j.1365-2133.2010.09848.x ID - Storch2010 ER - TY - STD TI - Epperla N, Brilliant MH, Vidaillet H. Topical timolol for treatment of epistaxis in hereditary haemorrhagic telangiectasia associated with bradycardia: a look at CYP2D6 metabolising variants. BMJ Case Rep. 2014;2014 ID - ref8 ER - TY - JOUR AU - Olitsky, S. E. PY - 2012 DA - 2012// TI - Topical timolol for the treatment of epistaxis in hereditary hemorrhagic telangiectasia JO - Am J Otolaryngol VL - 33 UR - https://doi.org/10.1016/j.amjoto.2011.10.011 DO - 10.1016/j.amjoto.2011.10.011 ID - Olitsky2012 ER - TY - JOUR AU - Hoag, J. B. AU - Terry, P. AU - Mitchell, S. AU - Reh, D. AU - Merlo, C. A. PY - 2010 DA - 2010// TI - An epistaxis severity score for hereditary hemorrhagic telangiectasia JO - Laryngoscope VL - 120 UR - https://doi.org/10.1002/lary.20818 DO - 10.1002/lary.20818 ID - Hoag2010 ER - TY - JOUR AU - Przewratil, P. AU - Sitkiewicz, A. AU - Andrzejewska, E. PY - 2010 DA - 2010// TI - Local serum levels of vascular endothelial growth factor in infantile hemangioma: intriguing mechanism of endothelial growth JO - Cytokine VL - 49 UR - https://doi.org/10.1016/j.cyto.2009.11.012 DO - 10.1016/j.cyto.2009.11.012 ID - Przewratil2010 ER - TY - JOUR AU - Albiñana, V. AU - Recio-Poveda, L. AU - Zarrabeitia, R. AU - Bernabéu, C. AU - Botella, L. M. PY - 2012 DA - 2012// TI - Propranolol as antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasia JO - Thromb Haemost VL - 108 UR - https://doi.org/10.1160/TH11-11-0809 DO - 10.1160/TH11-11-0809 ID - Albiñana2012 ER - TY - JOUR AU - Contis, A. AU - Gensous, N. AU - Viallard, J. F. AU - Goizet, C. AU - Leaute-Labreze, C. AU - Duffau, P. PY - 2017 DA - 2017// TI - Efficacy and safety of propranolol for epistaxis in hereditary haemorrhagic telangiectasia: retrospective, then prospective, study in a total of 21 patients JO - Clin Otolaryngol VL - 42 UR - https://doi.org/10.1111/coa.12821 DO - 10.1111/coa.12821 ID - Contis2017 ER - TY - JOUR AU - Yin, L. X. AU - Reh, D. D. AU - Hoag, J. B. AU - Mitchell, S. E. AU - Mathai, S. C. AU - Robinson, G. M. PY - 2016 DA - 2016// TI - The minimal important difference of the epistaxis severity score in hereditary hemorrhagic telangiectasia JO - Laryngoscope VL - 126 UR - https://doi.org/10.1002/lary.25669 DO - 10.1002/lary.25669 ID - Yin2016 ER - TY - JOUR AU - Hussain, A. AU - Foster, T. AU - Hirai, S. AU - Kashihara, T. AU - Batenhorst, R. AU - Jones, M. PY - 1980 DA - 1980// TI - Nasal absorption of propranolol in humans JO - J Pharm Sci VL - 69 UR - https://doi.org/10.1002/jps.2600691037 DO - 10.1002/jps.2600691037 ID - Hussain1980 ER -